Is Kanna Psychoactive? How It Affects the Brain
You've probably heard the word "psychoactive" and pictured something intense: hallucinations, altered perception, or a complete departure from reality. So when kanna (Sceletium tortuosum) gets labeled with that word, it's worth pausing and understanding what it means.
Most of what gets called psychoactive is far more nuanced than the cultural shorthand suggests. Kanna has been used for centuries across Southern Africa for mood support, stress relief, and social ease, and science is now catching up to what traditional communities always understood.
If you've been curious about how this plant works in the brain, and whether it belongs in your wellness routine, you've come to the right place.
Kamello is built on exactly this kind of ancient wisdom, combining kanna with noble kava in a ready-to-drink format designed for modern life. Here we will provide a clear-eyed breakdown of what kanna does and why the answer is more interesting than a simple yes or no.
Psychoactive Is Not a Dirty Word: Here's What It Really Means for Kanna
Your Morning Coffee Is Psychoactive Too
The word psychoactive simply refers to any compound that affects the brain and central nervous system, altering mood, cognition, or perception. By that definition, coffee is psychoactive. So is cacao, alcohol, and nicotine. The term describes a spectrum, not a danger level.
Kanna sits firmly on the gentle end of that spectrum. Its effects are tied to naturally occurring alkaloids that interact with brain chemistry in meaningful but mild ways. There are no visuals, no impaired judgment, and no trip to recover from.
Understanding this distinction matters because it changes how you evaluate kanna as a wellness option rather than writing it off based on a misread label. People seeking natural alternatives to alcohol and pharmaceutical interventions are increasingly asking whether kanna can offer real functional benefits. The answer is rooted in biochemistry.
Born in the Desert: The Ancient Plant Behind the Modern Buzz
Kanna is a small succulent native to the semi-arid Karoo and Namaqualand regions of South Africa.
The San and Khoikhoi peoples, some of the oldest continuous inhabitants of Southern Africa, have relied on it for millennia. They chewed it, brewed it as tea, used it as snuff, and incorporated it into spiritual and communal gatherings.
Early European colonial accounts from the 1660s documented its use for social bonding, endurance on long hunts, hunger and thirst suppression, and emotional steadiness under stress.
One of the most distinctive traditional preparations is kougoed, a fermented form of the plant made by crushing, pounding, and leaving the material to sweat for around eight days. This process was far more than a preservation technique.
Research published in the Journal of Ethnopharmacology found that fermentation converts mesembrenone into mesembrine, significantly shifting the alkaloid ratio and likely shaping the experience.
Indigenous communities discovered through generations of practice that preparation method changes what the plant does, a level of sophistication that modern science is only beginning to document.
For brands like Kamello, this heritage is not a marketing backdrop. It's the foundation of a formulation built around respect for what these plants do.
Inside the Brain on Kanna: A Chemistry Lesson Worth Having
The Serotonin Connection That Makes Kanna So Interesting
The primary active compounds in kanna are a class called mesembrine alkaloids, particularly mesembrine, mesembrenone, and mesembrenol. Each has a distinct but complementary role in how the plant affects the nervous system.
Mesembrine functions as a serotonin reuptake inhibitor, blocking the transporter that normally pulls serotonin back into neurons after it's released. The result is more of this neurotransmitter available in the synaptic space, supporting emotional regulation, easing tension, and promoting a sense of balance.
This mechanism is structurally similar to the class of pharmaceuticals known as SSRIs, though kanna operates at a different scale of effect and through a distinct molecular pathway.
A double-blind, placebo-controlled fMRI study published in Neuropsychopharmacology found that a single 25mg dose of Zembrin significantly reduced amygdala reactivity to threatening stimuli in 16 healthy participants and weakened its connectivity to the hypothalamus. This helps explain why users often report feeling less reactive to stressors and more grounded in social settings.
The Second Mechanism Most People Have Never Heard Of
Beyond serotonin, kanna has a second biochemical effect that most summaries overlook: phosphodiesterase 4 (PDE4) inhibition.
PDE4 is an enzyme that breaks down cyclic AMP, a signaling molecule involved in a range of neuronal functions. By inhibiting PDE4, kanna reduces the production of inflammatory cytokines and creates an anti-inflammatory effect at the neurological level.
This dual-action profile is what makes kanna particularly interesting from a neuroscience perspective. The serotonergic pathway supports emotional ease, while PDE4 inhibition supports reduced neurological inflammation and sharper cognitive function.
According to research from Examine.com, clinical studies have consistently used 25mg of a quality extract as the benchmark dose. Separate trials found that this amount taken daily for nine weeks improved executive function and cognitive flexibility in healthy subjects, evidence that this is a plant actively supporting how the brain performs under load, not just sedating it.
A 2014 randomized controlled trial published in Evidence-Based Complementary and Alternative Medicine confirmed these cognitive gains in detail.
What Kanna Feels Like When You Use It
Calm, Clear, and Sociable: Without the Morning Regret
People who use kanna consistently describe a recognizable but moderate shift in how they feel. Common reports include elevated spirits, reduced social anxiety, easier conversation, calm alertness, and mild euphoria that never tips into disorientation.
The experience has been compared to the early, pleasant stages of a glass of wine, without the alcohol, the impairment, or what comes after. Dose plays a significant role. Smaller amounts tend to produce gentle uplift and increased social ease, while larger amounts lean toward noticeable relaxation and a quieting of mental noise.
Neither end of that range produces hallucinations or the kind of altered state associated with stronger psychoactive substances. Research on quality extracts suggests an effective range of 25 to 50mg for most people, with results that are noticeable but not disorienting.
Delivery format also matters. Consistent, well-formulated products tend to produce more predictable results than raw plant material with variable alkaloid content. This is why quality is not a small detail. It's the difference between a reliable experience and an inconsistent one.
Is This Plant Safe to Use?
Available research supports a solid short-term safety profile for kanna at supplemental doses. Studies have not found significant toxicological effects in human subjects at these levels.
Unlike some plants in the same conversation, kanna has not been associated with dependency, withdrawal, or cognitive impairment at typical doses. That said, there are meaningful contraindications worth knowing.
People taking SSRIs or MAOIs should consult a healthcare provider before using kanna, given the overlapping neurochemical mechanism. The Office of Dietary Supplements and Safety (OPSS) also notes caution during pregnancy and when pairing kanna with alcohol or other psychoactive substances.
These are not reasons to avoid it. They are reasons to use it thoughtfully. For the wellness-focused adult using kanna in a carefully formulated beverage, the evidence points toward a low-risk, functional plant with a well-documented history.
Kamello is designed with this in mind: noble kava for body-level calm, kanna for lift and social ease, and no alcohol at any stage.
Why Kanna Is Having a Moment (and Why That Moment Is Well Earned)
The Sober-Curious Generation Has Found Its Botanical
There is a growing cultural shift away from alcohol as the default social lubricant. The sober-curious movement has created real demand for alternatives that can ease social tension, elevate the room, and make gatherings feel warmer without the downsides.
According to IWSR, functional alcohol-adjacent beverages grew 11% by volume in 2025, driven by consumers specifically seeking the functional effects of alcohol without intoxication. Millennials and Gen Z account for more than three-quarters of this consumer base.
Kanna addresses this directly through its serotonin-mediated effects, without the depressive impact alcohol has on the nervous system over time. This is not a niche preference. It reflects a fundamental shift in how a generation thinks about socializing and stress management.
How to Make Kanna Part of Your Routine
The pairing of kanna and kava works because the two plants act through different but reinforcing mechanisms. Kava's active compounds, kavalactones, modulate GABA receptors in the brain, the same system targeted by benzodiazepines, to produce physical relaxation without impairing cognition.
Peer-reviewed research published in PLOS ONE confirmed that kavain, the primary anxiolytic kavalactone, directly potentiates GABA-A receptors through a mechanism independent of classical benzodiazepine binding sites.
Kanna then works through the serotonin system to lift spirits and ease social barriers. Together, they cover the full range of what people often reach for alcohol to accomplish, without the aftermath.
Whether you are winding down after a demanding workday, navigating a social event where alcohol doesn't fit your goals, or building a more intentional daily routine, kanna offers a specific and well-researched kind of support.
The key is formulation quality and appropriate dosage, the same considerations that apply to any functional ingredient worth reaching for.
The Research Is In: What Clinical Science Says About Kanna
A Landmark Brain Study That Changed the Conversation
Zembrin is a patented, clinically studied extract of Sceletium tortuosum that has been the subject of multiple peer-reviewed trials.
The 2013 study published in Neuropsychopharmacology confirmed that the plant's dual serotonin reuptake inhibition and PDE4 inhibition profile produces measurable changes in how the brain responds to stress, results that validate centuries of traditional use in a controlled setting.
A separate nine-week randomized controlled trial found that 25mg daily improved executive function and cognitive flexibility. Researchers attributed the gains to kanna's effect on the cAMP-CREB signaling cascade, a pathway also being explored in Alzheimer's research.
Decades of Traditional Knowledge, Now in a Peer-Reviewed Database
A comprehensive 2021 review published in the Journal of Ethnopharmacology examined the properties of Sceletium tortuosum across decades of ethnobotanical and clinical literature.
The review confirmed the plant's history of use among the San and Khoikhoi, its alkaloid profile, and its growing role in supporting emotional balance and stress resilience.
Importantly, it found no significant toxicological concerns at supplemental doses and noted anti-inflammatory properties alongside the well-established neurochemical effects. For anyone who wants to go deeper than a blog post, this review is the place to start.
Ready to Feel What These Botanicals Can Do for Modern Life?
Kanna is psychoactive in the truest sense of the word: it acts on the brain, influences how you feel, and shifts your experience in social and emotional contexts. But that is very different from being intoxicating, destabilizing, or risky at appropriate doses.
What it offers is something increasingly rare: a plant-based, alcohol-free way to feel more at ease, more open, and more present without sacrificing clarity. This is exactly why Kamello pairs kanna with noble kava in a single, ready-to-drink format.
Each can is designed to deliver the benefits of both plants: physical relaxation from kava's kavalactones acting on GABA receptors, mood lift and social ease from kanna's serotonergic effects, and a clean exit from the experience with no hangover and no regret.
If you've been curious about what this kind of plant-powered ritual feels like in practice, this is your invitation. Ancient roots, modern can. Explore Kamello’s full range of drinks today and start your new relaxation ritual.
Frequently Asked Questions
Is kanna legal in the United States?
Kanna is not listed as a federally scheduled controlled substance in the United States, but that does not mean every kanna product is reviewed or approved by the FDA before sale.
The DEA explains that controlled substances are classified into five schedules under federal law, and the official schedule framework is maintained through federal controlled substance rules in the DEA’s drug scheduling overview.
In the U.S., kanna is generally sold in dietary supplement or functional beverage contexts, where companies are responsible for product safety, labeling, and truthful marketing. The FDA explains that dietary supplements are regulated under a different set of rules than conventional foods and drug products in its dietary supplement framework.
That distinction matters because “legal” is not the same as “FDA-approved to treat a health condition.” The FDA explains that dietary supplements generally do not require premarket approval for safety and effectiveness before they reach consumers, as outlined in the FDA’s questions and answers on dietary supplements.
State laws and retailer policies can also change, so people should not rely on a single “legal” label as the whole story. A more accurate way to understand kanna in the U.S. is that it is not federally scheduled, but products containing it still need to comply with FDA, FTC, state, and marketplace rules around labeling, advertising, safety, and disease claims, including the FTC’s standards for health product advertising claims.
Can kanna cause a positive result on a drug test?
Kanna’s main alkaloids, including mesembrine-type compounds, are not part of standard federal workplace drug testing panels.
SAMHSA lists federal workplace drug testing resources for the major workplace testing categories, and kanna is not included in those standard categories in SAMHSA’s workplace drug testing resources.
That makes a standard-panel positive result from kanna itself unlikely, but it is still wise to be cautious. Some employers, athletic organizations, military programs, or legal monitoring programs may use expanded or customized testing, and supplement products can also vary in quality.
The Federal Register’s notice on authorized federal workplace testing panels is useful because it clarifies what is currently included in federal workplace testing, but it does not cover every private or specialized testing situation.
The bigger issue is product integrity. OPSS notes that some kanna-containing supplements have been found to contain undeclared ingredients such as hordenine or ephedrine, which makes third-party testing especially important for anyone subject to strict testing rules, military policies, or workplace compliance programs.
Anyone who is regularly tested should treat supplement quality as a compliance issue, not just a wellness preference.
Choosing products with transparent ingredient panels, clear serving sizes, and batch-level testing can reduce avoidable risk, especially when a job, athletic eligibility, or military status depends on clean testing outcomes, and OPSS specifically encourages caution with products that may contain undeclared substances in its dietary supplement safety guidance.
Can kanna be used alongside other adaptogens or functional ingredients?
Kanna can appear in formulas with other botanicals, amino acids, or functional ingredients, but combining ingredients does not automatically make a product safer or more effective.
The safest way to think about combinations is by mechanism: a placebo-controlled human brain-imaging study described standardized Sceletium tortuosum extract as a dual 5-HT reuptake and PDE4 inhibitor, which is why overlapping serotonergic, sedating, stimulating, or mood-active substances can make effects harder to predict.
This is especially important for people using SSRIs, SNRIs, MAOIs, stimulant medications, sedatives, sleep aids, alcohol, cannabis, or multiple mood-focused supplements.
Serotonin toxicity is uncommon, but risk increases when serotonergic substances are combined, and a clinical review in Canadian Family Physician notes that combining an MAOI with another serotonergic drug is among the higher-risk scenarios for serotonin toxicity.
For a functional beverage, a well-formulated blend should be clear about serving size, ingredient amounts, and intended use. If a formula contains several mood-active botanicals at once, more is not necessarily better.
OPSS emphasizes that human kanna studies are still small and short-term, and that more research is needed to confirm benefits and define safety across real-world use patterns in its kanna safety overview.
The most defensible approach is to avoid building a “stack” by combining several new mood-active ingredients on the same day. Trying one product at a time makes it easier to understand personal response, avoid overlapping effects, and notice side effects such as drowsiness, agitation, headache, nausea, or changes in alertness, which OPSS identifies as possible concerns in its kanna supplement safety discussion.
How quickly does kanna take effect?
Some people report noticing kanna within the first hour, but published human research does not establish one universal onset window for every product type. Timing can vary based on the extract, serving size, delivery format, food intake, individual metabolism, and whether the product is a beverage, capsule, tincture, powder, or traditional preparation.
Human studies do support that standardized Sceletium tortuosum extracts can produce measurable acute effects under controlled conditions. In one placebo-controlled pharmaco-fMRI study, researchers evaluated a single dose of standardized Sceletium extract and observed changes in stress-related brain circuitry.
For consumer use, the most defensible guidance is to start with the labeled serving size and avoid taking more too soon. Because effects can vary from person to person, it is better to treat kanna like a functional botanical with individualized timing rather than a substance with a guaranteed minute-by-minute onset and duration, especially because the broader Sceletium research base is still limited, as noted in a peer-reviewed review on Sceletium in modern regulatory systems.
A slower or subtler response does not necessarily mean a product is ineffective.
Food intake, hydration, sleep, stress level, and sensitivity to botanicals can all influence how noticeable kanna feels, so patience and consistency are more appropriate than repeated servings in a short period of time, especially with psychoactive dietary ingredients that OPSS recommends approaching cautiously in its kanna safety overview.
Is kanna the same as kratom?
No. Kanna and kratom are different plants with different origins, different alkaloids, and different primary pharmacological profiles.
Kanna refers to Sceletium tortuosum, a South African succulent studied mainly for mesembrine-type alkaloids and activity involving serotonin transport and PDE4, as described in the Nature-published human study on Sceletium’s 5-HT reuptake and PDE4 activity.
Kratom refers to Mitragyna speciosa, a Southeast Asian tree that contains alkaloids such as mitragynine and 7-hydroxymitragynine. The FDA explains that kratom compounds can bind to mu opioid receptors and that kratom is not lawfully marketed in the U.S. as a drug product, dietary supplement, or conventional food additive in the FDA’s kratom safety overview.
The safety conversation is also different. The FDA has warned consumers about kratom because of reported risks including liver toxicity, seizures, substance use disorder, and serious adverse events, as described on the FDA’s kratom safety page. Kanna should still be used thoughtfully, but it should not be treated as interchangeable with kratom.
This distinction matters because “plant-based” does not describe how a substance works in the body. Two botanicals can both be natural while having completely different receptor activity, risk profiles, legal treatment, and appropriate use cases, which is why kanna’s serotonin and PDE4 activity should be evaluated separately from kratom’s opioid-receptor activity.
Who should avoid kanna or ask a healthcare professional first?
People who are pregnant, breastfeeding, taking psychiatric medications, using MAOIs, SSRIs, SNRIs, stimulants, sedatives, or combining multiple psychoactive substances should avoid kanna unless a qualified healthcare professional says it is appropriate for their situation.
OPSS specifically notes that kanna safety evidence is limited, that studies have generally been small and short-term, and that caution is warranted in pregnancy and with alcohol or other psychoactive substances in its kanna uses and safety guidance.
People with bipolar disorder, a history of mania, seizure disorders, significant liver disease, complex medication regimens, or sensitivity to mood-active supplements should also be cautious. This is not because kanna has been proven unsafe for all of these groups, but because its serotonergic activity and limited long-term human data leave important unanswered questions.
A peer-reviewed review of Sceletium research describes the plant’s traditional use and modern regulatory questions, which supports a cautious approach for higher-risk groups in the review on Sceletium in modern regulatory systems.
Kanna should also be avoided before driving, operating machinery, or doing safety-sensitive work until someone knows how they personally respond. OPSS lists possible side effects such as headache, gastrointestinal discomfort, fatigue, drowsiness, and difficulty concentrating, which are exactly the kinds of effects that matter in situations requiring alertness and coordination.
Anyone scheduled for surgery or a medical procedure should also disclose kanna and other supplements to their healthcare team. The FDA advises consumers to tell healthcare professionals about supplement use because supplements can interact with medicines, medical conditions, and procedures, as explained in the FDA’s consumer guidance on dietary supplements.